Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/011040 stock hub

KOSDAQ/011040 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/011040is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

149.3B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/011040

In the news

Latest news · KOSDAQ/011040

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E17.6

P25 n/aP50 n/aP75 n/a

ROE3.8

P25 n/aP50 n/aP75 n/a

ROIC3.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/011040 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

KRW

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	350
Enterprise value	KRW 148.2B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 149.3B
Price	KRW 5,540
Price currency	KRW
Rev Per Employee	560,780,122.2x
Sic	2834
Symbol	kosdaq/011040
Website	https://www.kdpharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.71%
EV Earnings	17.38x
EV/EBIT	19.5x
EV/EBITDA	13.14x
EV/FCF	-101.49x
EV/Sales	0.76x
FCF yield	-0.98%
P/B ratio	0.65x
P/E ratio	17.59x
P/S ratio	0.76x
PE Ratio10 Y	23.85x
PE Ratio3 Y	25.69x
PE Ratio5 Y	25.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.91%
EBITDA Margin	5.78%
Gross margin	59.66%
Gross Profit	KRW 117.1B
Gross Profit Growth	2.39%
Gross Profit Growth Q	7.31%
Gross Profit Growth3 Y	6.88%
Gross Profit Growth5 Y	3.36%
Net Income	KRW 8.5B
Net Income Growth	55.93%
Net Income Growth Q	9.51%
Net Income Growth3 Y	-11.15%
Net Income Growth5 Y	-7.3%
Pretax Margin	4.65%
Profit Margin	4.35%
Profit Per Employee	KRW 24.4M
ROA	1.53
Roa5y	0.4
ROCE	3.04
ROE	3.76
Roe5y	1.43
ROIC	3.16
Roic5y	0.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.01%
Cagr15y	5.99%
Cagr1y	0.12%
Cagr20y	2.63%
Cagr3y	-4.36%
Cagr5y	-7.28%
Div CAGR10	0%
Div CAGR3	-9.14%
Div CAGR5	-9.71%
EPS Growth	55.17
EPS Growth Q	6.77
EPS Growth3 Y	-11.01
EPS Growth5 Y	-9.11
OCF Growth Q	-59.97%
OCF Growth10 Y	-0.75%
OCF Growth5 Y	-0.21%
Revenue Growth	1.21x
Revenue Growth Q	5.32x
Revenue Growth3 Y	2.41x
Revenue Growth5 Y	2.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.63
Assets	KRW 321.9B
Cash	KRW 47B
Current Assets	KRW 112.8B
Current Liabilities	KRW 69.6B
Debt	KRW 45.4B
Debt EBITDA	KRW 4.01
Debt Equity	KRW 0.2
Debt FCF	KRW -31.12
Equity	KRW 228.9B
Interest Coverage	4.32
Liabilities	KRW 93B
Long Term Assets	KRW 209.1B
Long Term Liabilities	KRW 23.4B
Net Cash	KRW 1.6B
Net Cash By Market Cap	KRW 1.04
Net Debt EBITDA	KRW -0.14
Net Debt Equity	KRW -0.01
Tangible Book Value	KRW 223.4B
Tangible Book Value Per Share	KRW 8,235
WACC	6.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.62
Inventory Turnover	1.81
Net Working Capital	KRW 26.3B
Quick ratio	0.99
Working Capital	KRW 43.2B
Working Capital Turnover	KRW 5.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.49%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 300
Dividend Years	27
Dividend Yield	5.42%
Ex Div Date	2025-12-29
Last Dividend	KRW 300
Payout Frequency	Annual
Payout Ratio	94.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	0.11%
1Y total return	0.12%
200-day SMA	5,793.7
3Y total return	-12.52%
50-day SMA	5,532.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-31.47%
All Time High	18,300
All Time High Change	-69.73%
All Time High Date	2020-07-24
All Time Low	424.2
All Time Low Change	1,205.96%
All Time Low Date	2000-09-22
ATR	96.92
Beta	0.46
Beta1y	0.23
Beta2y	0.23
Ch YTD	-5.14
High	5,550
High52	6,890
High52 Date	2025-08-26
High52ch	-19.59%
Low	5,460
Low52	5,290
Low52 Date	2026-03-04
Low52ch	4.73%
Ma50ch	0.13%
Price vs 200-day SMA	-4.38%
RSI	47.25
RSI Monthly	39.37
RSI Weekly	43.75
Sharpe ratio	-0.08x
Sortino ratio	0.24
Total Return	4.93%
Tr YTD	-5.14
Tr15y	139.45%
Tr1m	3.75%
Tr1w	-1.6%
Tr3m	-0.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 7.7B
Operating Income Growth	192.2
Operating Income Growth Q	15.4
Operating Income Growth3 Y	-2.66
Operating Income Growth5 Y	-17.21
Operating margin	3.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,858,632%
Net Borrowing	9,679,742,850
Shares Insiders	41.08%
Shares Institutions	0.63%
Shares Out	26,941,770
Shares Qo Q	1.96%
Shares Yo Y	0.49%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -1.5B
Average Volume	32,012.8x
Bv Per Share	8,417.9
CAPEX	KRW -18.4B
Ch10y	-36.14
Ch15y	24.36
Ch1m	3.75
Ch1w	-1.6
Ch1y	-4.81
Ch20y	-30.75
Ch3m	-0.36
Ch3y	-25.44
Ch5y	-46.73
Ch6m	-3.15
Change	-0.36%
Change From Open	-0.18
Close	5,560
Days Gap	-0.18
Depreciation Amortization	3,677,848,490
Dollar Volume	123,409,040
Earnings Date	2026-08-13
EBIT	KRW 7.7B
EBITDA	KRW 11.3B
EPS	KRW 315
F Score	6
FCF	KRW -1.5B
FCF EV Yield	-0.99x
FCF Per Share	KRW -54.21
Financing CF	198,615,690
Fiscal Year End	December
Founded	1,975
Goodwill	61,199,000
Graham Number	7724.09403
Graham Upside	39.42
Income Tax	KRW 672M
Investing CF	-1,142,520,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2018-04-20
Last Split Type	Forward
Lynch Fair Value	KRW 1,575
Lynch Upside	-71.57
Ma150	5,727.9
Ma150ch	-3.28%
Ma20	5,580
Ma20ch	-0.72%
Net CF	16,040,054,840
Next Earnings Date	2026-08-13
Open	5,550
P OCF Ratio	8.81
Payment Date	2026-04-17
Position In Range	88.89
Ppne	87,376,802,150
Price Date	2026-05-08
Price EBITDA	KRW 13.16
Ptbv Ratio	0.67
Relative Volume	0.7x
Revenue	196,273,042,770x
Tax By Revenue	0.34x
Tax Rate	7.37%
Tr20y	68.17%
Tr6m	1.87%
Volume	22,276
Z Score	2.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/011040 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.4%

$300 annual per share

Payout ratio

+94.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.7%

0 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2025-12-29

Performance

KOSDAQ/011040 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/011040?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+41.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

KOSDAQ/011040 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-4.4%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

-0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/011040

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/011040 stock rating?

kosdaq/011040 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/011040 analysis?

The full report lives at /stocks/kosdaq/011040/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/011040?

The latest report frames kosdaq/011040 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/011040 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.